Treatment of embolic stroke as a medical emergency. Implications in a managed care environment.
Encouraging innovations should be a concern of the providers/gatekeepers of health-care if lower health-care costs are to become a reality. Controlled prices and improper incentives will dramatically slow innovation in American medicine. For the vertically integrated health-care system providing capitated coverage, the aggressive treatment of stroke is a sound financial decision.
Lanzieri
C F
CF
Department of Radiology, Case Western Reserve University School of Medicine, University Hospitals of Cleveland, Cleveland, Ohio 44106, USA.
D002561:Cerebrovascular Disorders / Q000191:economics; D003362:Cost-Benefit Analysis; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000191:economics* / Q000628:therapy*; D008329:Managed Care Programs / Q000191:economics*; D017059:Models, Econometric; D010960:Plasminogen Activators / Q000191:economics / Q000627:therapeutic use; D014481:United States
D010960:Plasminogen Activators